transcriptional activity . >https://pharma. lonza. com/offerings/specialized-capabilities/expressions-technologies/GS-piggyBac >
Innovent Bio announced that its anti-CTLA-4 monoclonal antibody IBI310 has been included
Time of Update: 2022-05-20
. Advanced cervical cancer The existing treatment methods for patients are very limited, chemotherapy and other treatments are ineffective, the overall survival rate of patients is only a few months, and new
AACR 2022: NK Cells and Bispecific Antibody AFM13 Complexes Consistently Induce Lymphoma Remission
Time of Update: 2022-05-18
>Original source:>Original source:https://firstwordpharma. com/story/5545475>https
" neutralizing antibody 35B5 neutralizes the Omicron strain and its mechanism
Time of Update: 2022-05-18
Since its discovery in November last year, the SARS-CoV-2 superstrain Omicron has rapidly spread globally and has gradually replaced the previous Variants of Concern (VOCs) that were identified
The 9th domestic Yuheng Pharmaceutical LAG3 monoclonal antibody was approved for clinical use
Time of Update: 2022-05-18
Article source: Medical Cube InfoAuthor: sunshineOn April 19, the CDE official website showed that Yuheng Pharmaceutical's recombinant fully human anti-LAG-3 monoclonal antibody injection was approved for clinical use in the treatment of advanced malignant tumors .
AstraZeneca's new crown antibody cocktail therapy can provide protection for at least 6 months in high-risk groups
Time of Update: 2022-05-17
AstraZeneca said today that its long-acting antibody cocktail, Evusheld (tixagevimab and cilgavimab), compared with placebo in a late-stage pre-exposure prophylaxis trial, reduced patients with symptomatic COVID-19 infection six months later.
EBioMedicine: Novel coronavirus mRNA vaccine induces higher antibody affinity and IgG titers
Time of Update: 2022-05-16
) of polyclonal antibodies to 2019-nCoV RBD protein for post-first (Vx-1; a) or post-secondary vaccination (Vx-2; b) Peak titers per vaccination (day 14) in plasma samples of non-postpartum controls (n = 13 black) or postpartum women (n = 13 red) were
FDA extends review of COVID-19 antibody cocktail REGEN-COV as pre-exposure prophylaxis
Time of Update: 2022-05-16
However, the FDA restricted the use of certain antibody treatments, including REGEN-COV, earlier this year after data suggested they were unlikely to be effective against the Omicron variants .
Phase 3 clinical trial: second-generation new crown vaccine produces high levels of neutralizing antibodies
Time of Update: 2022-05-15
The novel coronavirus infection (COVID-19 virus) vaccine developed by the University of Washington School of Medicine has been shown to be safe and effective in late-stage clinical trials .
Acta Haematol: Unique mechanism of IgM antibody-mediated acquired von Willebrand syndrome
Time of Update: 2022-05-15
There were no reports of bleeding in the patient's past or family history, and laboratory tests showed decreased VWF antigen and VWF activity .
BeiGene's CD3/CD19 Dual Antibody Belintoumumab New Indication Approved
Time of Update: 2022-05-14
Article source: Medical Cube Info>Author: info>On April 29, BeiGene's new indication of belintoumumab for injection submitted
TNF-α antibody drug market competition is becoming more and more intense, and product price reduction has become a trend
Time of Update: 2022-05-10
In the domestic market, in recent years, with the continuous entry of infliximab and adalimumab biosimilar companies, the TNF-α antibody drug market has become more competitive, and product price reductions have become a trend .
Three inspirations from the CDE double antibody R&D guidelines for the industry
Time of Update: 2022-05-08
>At present, there are 11 double-antibody products in the phase III clinical/marketing application stage in the world, 4 of which are independently developed by China, and 2 of which are owned by Aesco, including Cardonili (PD-1/CTLA-4, which has been
Severe obesity impairs antibody response to COVID-19 vaccine, study shows
Time of Update: 2022-05-08
/> The research was conducted by Professor Volkan Demirhan Yumuk and colleagues at Istanbul University, Turkey . >The study also found that people with severe obesity
BeiGene's Bispecific Antibody Therapy Approved in China to Treat Certain Childhood Leukemia
Time of Update: 2022-05-08
A few days ago, BeiGene announced that the National Medical Products Administration (NMPA) of China has approved Belito (Belintoumumab for injection, English trade name Blincyto
